MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.amjcard.2009.02.056

Медицинская библиотека · The American journal of cardiology · 2009

Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

Noseworthy Peter A, Rosenberg Michael A, Fifer Michael A, Palacios Igor F, Lowry Patricia A, Ruskin Jeremy N, Sanborn Danita M, Picard Michael H, Vlahakes Gus J, Mela Theofanie, Das Saumya

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

We sought to assess the risk of sudden cardiac death (SCD) and ventricular arrhythmia after alcohol septal ablation (ASA) for obstructive hypertrophic cardiomyopathy. ASA is a nonsurgical alternative to septal myectomy for treatment of symptomatic, drug-refractory, obstructive hypertrophic cardiomyopathy. The effect of ASA on ventricular arrhythmia risk is not well established. We examined the rates of SCD among 89 patients treated with ASA. The secondary end point was ventricular tachycardia/ventricular fibrillation (VT/VF), appropriate implantable cardioverter defibrillator (ICD) therapy, or cardiac arrest after ASA among those with implanted ICDs or permanent pacemakers (n = 42). Patients were classified as either high-risk or low-risk on the basis of established clinical indications for ICD implantation. No mortality was attributable to SCD at a mean follow-up of 5.0 +/- 2.3 years in the entire cohort. Among the 42 patients with an ICD or permanent pacemaker, 9 had documented VT/VF, cardiac arrest, or appropriate ICD therapy, resulting in an annual event rate of 4.9%/year. The annual event rate for VT/VF, cardiac arrest, or appropriate ICD therapy was 2.8%/year (4 of 29 patients) in low-risk patients and 13.4% in high-risk patients (5 of 13 patients). A 10-mm Hg increase in the immediate post-ASA gradient was associated with a hazard ratio of 2.66 for arrhythmic events (95% confidence interval 1.55 to 4.56, p <0.001). In conclusion, ASA was performed in patients with highly symptomatic, drug-refractory hypertrophic cardiomyopathy with no mortality attributable to SCD and an annual rate of VT/VF, cardiac arrest, or appropriate ICD therapy of 4.9%/year.

Для цитирования: Noseworthy Peter A, Rosenberg Michael A, Fifer Michael A, Palacios Igor F, Lowry Patricia A, Ruskin Jeremy N, Sanborn Danita M, Picard Michael H, Vlahakes Gus J, Mela Theofanie, Das Saumya. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.. The American journal of cardiology. 2009. DOI: 10.1016/j.amjcard.2009.02.056.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.